FIELD: medicine.
SUBSTANCE: method involves determining general cholesterol, high density lipoprotein cholesterol, leukocytic intoxication index, leukocyte shift index. General cholesterol value falling below 2.5 mmole/l, high density lipoprotein cholesterol below 0.9, leukocytic intoxication index growing above 4.0 and leukocyte shift index above 6.0, unfavorable treatment outcome is to be predicted.
EFFECT: high accuracy of early stage prognosis.
3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF PREDICTION THE RISK OF UNFAVORABLE OUTCOME IN PATIENTS WITH DIFFUSE PERITONITIS | 2023 |
|
RU2794829C1 |
| METHOD FOR PREDICTION OF OUTCOME OF WIDESPREAD PURULENT PERITONITIS | 2012 |
|
RU2498300C1 |
| METHOD FOR PREDICTION OF EARLY POST-INFARCTION ANGINA IN PATIENTS WITH ACUTE ST-ELEVATION MYOCARDIAL INFARCTION ACROSS STAYING IN HOSPITAL | 2014 |
|
RU2543356C1 |
| CYTOMETRIC METHOD FOR PREDICTION OF CLINICAL OUTCOME OF WIDESPREAD PURULENT PERITONITIS | 2018 |
|
RU2691742C1 |
| METHOD FOR DIAGNOSING AND PREDICTING CARDIAC ISCHEMIA DISEASE | 1999 |
|
RU2173853C2 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF LIPIDEMIA | 2019 |
|
RU2714689C1 |
| METHOD FOR PREDICTING COMPLEX TREATMENT OUTCOME IN TREATING PATIENTS FOR GENERALIZED PURULENT PERITONITIS WHEN INTRA-ABDOMINALLY INTRODUCING IMOSIMASE | 2003 |
|
RU2275632C2 |
| METHOD FOR CORRECTION OF LIPOPEROXIDATION ACCOMPANYING HYPOLIPIDEMIC THERAPY OF PATIENTS WITH METABOLIC SYNDROME | 2011 |
|
RU2458687C1 |
| METHOD OF RISK EVALUATION OF METABOLIC SYNDROME IN PATIENTS WITH CHRONIC CHOLECYSTITIS | 2009 |
|
RU2403868C1 |
| METHOD FOR PREDICTION OF RISK OF UNFAVOURABLE OUTCOME OF POSTOPERATIVE CLINICAL COURSE OF PERITONITIS, COMPLICATED BY ABDOMINAL SEPSIS | 2015 |
|
RU2598743C1 |
